DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,854,235 | +4.7% | 15,535 | +1.2% | 0.11% | +7.8% |
| Q2 2023 | $3,682,821 | -25.0% | 15,345 | -21.3% | 0.10% | -28.5% |
| Q1 2023 | $4,911,273 | -3.7% | 19,486 | +1.4% | 0.14% | -8.3% |
| Q4 2022 | $5,100,594 | +9.7% | 19,217 | +6.8% | 0.16% | -1.3% |
| Q3 2022 | $4,648,000 | +0.5% | 17,994 | -1.3% | 0.16% | +4.6% |
| Q2 2022 | $4,624,000 | -4.1% | 18,240 | +11.0% | 0.15% | +10.1% |
| Q1 2022 | $4,821,000 | +15.9% | 16,438 | +30.0% | 0.14% | +17.9% |
| Q4 2021 | $4,159,000 | +13.9% | 12,641 | +5.4% | 0.12% | -10.0% |
| Q3 2021 | $3,653,000 | +16.3% | 11,999 | +2.6% | 0.13% | +14.0% |
| Q2 2021 | $3,140,000 | +39.4% | 11,700 | +16.9% | 0.11% | +29.5% |
| Q1 2021 | $2,253,000 | +2.5% | 10,010 | +1.2% | 0.09% | -2.2% |
| Q4 2020 | $2,197,000 | +2.7% | 9,887 | -0.5% | 0.09% | -7.2% |
| Q3 2020 | $2,140,000 | +19.4% | 9,938 | -1.9% | 0.10% | +7.8% |
| Q2 2020 | $1,792,000 | +26.5% | 10,134 | -1.0% | 0.09% | +3.4% |
| Q1 2020 | $1,417,000 | -10.4% | 10,240 | -0.6% | 0.09% | +7.4% |
| Q4 2019 | $1,582,000 | -24.4% | 10,304 | -28.9% | 0.08% | -31.4% |
| Q3 2019 | $2,093,000 | +2.6% | 14,491 | +1.4% | 0.12% | +1.7% |
| Q2 2019 | $2,039,000 | +60.0% | 14,287 | +48.1% | 0.12% | +52.6% |
| Q1 2019 | $1,274,000 | +34.1% | 9,650 | +4.7% | 0.08% | +20.6% |
| Q4 2018 | $950,000 | -2.2% | 9,218 | +3.2% | 0.06% | +12.5% |
| Q3 2018 | $971,000 | -26.2% | 8,934 | -33.0% | 0.06% | -33.3% |
| Q2 2018 | $1,315,000 | -0.4% | 13,326 | -1.1% | 0.08% | 0.0% |
| Q1 2018 | $1,320,000 | +5.8% | 13,480 | +0.3% | 0.08% | +10.5% |
| Q4 2017 | $1,248,000 | +8.2% | 13,435 | 0.0% | 0.08% | +1.3% |
| Q3 2017 | $1,153,000 | -1.1% | 13,435 | -2.8% | 0.08% | -2.6% |
| Q2 2017 | $1,166,000 | -11.3% | 13,815 | -10.2% | 0.08% | -12.5% |
| Q1 2017 | $1,315,000 | +7.3% | 15,376 | -2.4% | 0.09% | +4.8% |
| Q4 2016 | $1,226,000 | -7.0% | 15,754 | -6.3% | 0.08% | -12.5% |
| Q3 2016 | $1,318,000 | -25.1% | 16,811 | -3.5% | 0.10% | -27.3% |
| Q2 2016 | $1,759,000 | +0.6% | 17,418 | -5.6% | 0.13% | -4.3% |
| Q1 2016 | $1,749,000 | +3.1% | 18,442 | +1.0% | 0.14% | -1.4% |
| Q4 2015 | $1,696,000 | +13.0% | 18,259 | +3.6% | 0.14% | +6.9% |
| Q3 2015 | $1,501,000 | -0.5% | 17,619 | 0.0% | 0.13% | +10.1% |
| Q2 2015 | $1,508,000 | -8.8% | 17,619 | -9.6% | 0.12% | -10.5% |
| Q1 2015 | $1,654,000 | -3.9% | 19,481 | -3.0% | 0.13% | -5.0% |
| Q4 2014 | $1,721,000 | +12.8% | 20,081 | 0.0% | 0.14% | +15.7% |
| Q3 2014 | $1,526,000 | -5.4% | 20,081 | -2.0% | 0.12% | -4.7% |
| Q2 2014 | $1,613,000 | +5.6% | 20,491 | +0.6% | 0.13% | +0.8% |
| Q1 2014 | $1,528,000 | -2.4% | 20,376 | +0.4% | 0.13% | -3.8% |
| Q4 2013 | $1,566,000 | -0.4% | 20,286 | -10.5% | 0.13% | -7.7% |
| Q3 2013 | $1,572,000 | +12.2% | 22,676 | +2.4% | 0.14% | +6.8% |
| Q2 2013 | $1,401,000 | – | 22,140 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |